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Summary: One of the key ingredients in drug discovery is the derivation of conceptual templates
called pharmacophores. A pharmacophore model characterises the physico-chemical properties com-
mon to all active molecules, called ligands, bound to a particular protein receptor, together with
their relative spatial arrangement. Motivated by this important application, we develop a Bayesian
hierarchical model for the derivation of pharmacophore templates from multiple configurations of
point sets, partially labelled by the atom type of each point. The model is implemented through
a multi-stage template hunting algorithm which produces a series of templates that capture the
geometrical relationship of atoms matched across multiple configurations. Chemical information is
incorporated by distinguishing between atoms of different elements, whereby different elements are
less likely to be matched than atoms of the same element. We illustrate our method through examples
of deriving templates from sets of ligands which all bind structurally related protein active sites. The
resulting templates are considered to be plausible by experts with respect to the chemical affinity
of the subsets of molecules used to derive them.
Key words: Alignment; ligands; MCMC; pharmacophore; shape analysis; spatial matching; tem-
plate.
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1. Introduction
One of the key ingredients in drug discovery is the derivation of conceptual templates called
pharmacophores. A pharmacophore model is a specific three-dimensional map of chemical
properties common to active conformations of a set of small molecules, known as ligands, that
exhibit a particular biological activity. A pharmacophore model can be generated from three-
dimensional structural data describing ligands and their interaction with a particular protein
receptor site. Currently, this is often done manually by inspection and expert judgement,
see for example Rella et al. (2006). We note that methods for the multiple alignment of
configurations have been proposed by, for example, Ruffieux and Green (2008) and Dryden,
Hirst and Melville (2007), but these methods are not specifically tailored to producing
pharmacophore templates from matched points. Hence, there is a need to develop a statistical
methodology which simultaneously enables the automated identification of pharmacophore
models and the quantification of their plausibility. For more details on the pharmacophore
concept, see Leach and Gillet (2003, Chapter 3).
It is common to represent structures of protein-ligand complexes as configurations of points
in R3, with each point representing the location of an individual atom. Pharmacophore
identification is therefore reduced directly to the problem of finding points common to a
set of configurations. Motivated by this, we develop a hierarchical model for the derivation
of pharmacophore templates. The method identifies common matched points from multiple
configurations, or subsets of them, and builds a hierarchy of templates capturing the geometry
of the matched points. We also consider the chemical plausibility of the templates, through
the use of chemical information to distinguish between atoms of different elements, with the
interpretation that different elements are less likely to be matched than atoms of the same
element type. This ensures that the resulting templates are sensible with regards to their
chemical properties, as well as their geometry.
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Within our model, we require the use of a method for the pairwise alignment of two con-
figurations. Here we use the pairwise alignment method described by Green and Mardia
(2006), which provides us with many of the ingredients needed to implement our strategy. An
alternative method could easily be substituted; all that we require is a method that estimates
which atoms match and the corresponding probabilities, allowing a “score” rating the overall
quality of matching between two ligands to be computed. We then use the output from these
alignments within a multi-stage algorithm for building templates, which requires the use of
a scoring function for discriminating between various pairwise alignments at each stage. The
templates are formed hierarchially, successively merging configurations or previously formed
templates, using only the common matched points identified from the pairwise alignments.
Our proposed algorithm is capable of identifying multiple subsets of configurations and
outputs templates representing the matched points in each.
An outline of this article is as follows. We describe the model behind our methodology in
Section 2. In Section 3, we consider the implementation of our model and outline an example
iteration of the algorithm for a fixed number of configurations. In Section 4 we consider two
applications of our method to finding points common to subsets of ligands which are bound
to related protein active sites. Finally, we discuss the proposed methodology in Section 5.
2. Methodology
We consider using data obtained from the multiple alignment of protein binding sites to
produce pharmacophore templates from a set of ligands. The data is in the form of ligands
reduced to point configurations in three-dimensional space, with each point partially labelled
by element type of the atom at that point. In this paper, we assume we have three-dimensional
data but the method can easily be extended to d 6= 3 dimensions. We have ligand configu-
rations xi: i = 1, . . . , C of sizes ni. That is, configuration i contains ni points (atoms). The
aim is to construct a template, µ0 say, comprising of n0 atoms, where n0 is unknown. We set
Hierarchical Bayesian Modelling of Pharmacophores in Bioinformatics 3
out to identify n0 common points in a set of configurations I, where I ⊆ {xi} and {xi} is the
set of all configurations. Candidate templates are formed from pairwise alignments between
individual configurations and/or previously constructed templates, and these are evaluated
with a scoring function which we use to select the best candidate at each stage. Hence, we
require the use of a method for the pairwise alignment of two configurations. Here we use the
method described by Green and Mardia (2006), the output from which we can use to build
candidate templates at each stage and evaluate them according to our scoring function. We
will henceforth refer to this method as the Green-Mardia (GM) algorithm. Below, we first
briefly describe the GM algorithm, before describing our proposal for a hierarchical template
model, which we will refer to as the HT algorithm.
2.1 The GM pairwise alignment algorithm
Green and Mardia (2006) describe the pairwise alignment of two configurations using a
fully Bayesian aproach. Consider aligning a pair of configurations x and y under rigid body
transformations. Denote the jth atom in the x configuration by xj where j = 1, . . . , m.
Similarly, yk denotes the k
th atom in the y configuration where k = 1, . . . , n. Let A and
τ denote the rotation matrix and translation vector to bring y into alignment with x.
Furthermore denote prior distributions on these parameters by p(A) and p(τ). We denote
the prior for σ, parameterising noise in atomic positions for x and y coordinates, by p(σ).
The joint posterior distribution for the model is
p(M,A, τ, σ, x, y) ∝ p(A)p(τ)p(σ)×
∏
j,k:Mjk=1
(
κ
φ({xj −Ayk − τ}/σ√2)
(σ
√
2)3
)
, (1)
where φ(·) is the standard normal probability density function and κ > 0 is a parameter
representing the propensity of points to be matched. M is an unknown matrix for matching
between points on each configuration, where
Mjk =


1 if xj corresponds to yk
0 otherwise.
(2)
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We also use the priors
A ∼ uniform, τ ∼ N(0, σ2τI3), σ−2 ∼ Γ(α, β). (3)
Euler angles, θ12, θ13 and θ23 say, are used to parameterise the rotation matrix as a product
of elementary rotations, such that
A = A12(θ12)A13(θ13)A23(θ23),
where −pi < θ12, θ23 < pi and −pi/2 < θ13 < pi/2 (see Green and Mardia, 2006). The uniform
measure is then cos θ13dθ12dθ13dθ23.
A point estimate of M , M̂ , is found by minimising the point-wise error rates P (M̂jk =
1|Mjk = 0) and P (M̂jk = 0|Mjk = 1) and is controlled by the cost ratio, K, of falsely
matching points. The posterior probability that the pair of points (j, k) are a match, pjk =
P (Mjk = 1|x, y), is given by the empirical frequency of this match from an MCMC run and
M̂ is a solution to a “linear assignment” problem with cost matrix (pjk −K). A standard
linear assignment program (lpsolve, Berkelaar, 1996) is then used to find M̂ , with the cost
matrix (pjk −K)+.
2.2 The Hierarchical Templates (HT) model
We denote the jth atom in the ith configuration by xij , j = 1, . . . , ni. Similarly, the j
′th atom
in the template is denoted by µ0j′. LetMi = (Mijj′) be the matching matrix for the i
th ligand
and µ0, where
Mijj′ =


1 if xij corresponds to µ0j′
0 otherwise.
(4)
Also let Ai and τi, i = 1, . . . , |I| be rotation matrices and translation vectors to register
xi with respect to µ0. For given µ0j′, and for each j
′ such that Mijj′ = 1, we assume the
likelihood
Aixij + τi|µ0j′ ∼ N(µ0j′, σ2I3). (5)
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We use a Bayesian formulation where the priors for Ai, τi and σ
−2 are as in (3) and µ0 has
a uniform prior. We assume an exchangeable prior for Mijj′ with the geometric probability
distribution
p(Mijj′) ∝ (κ)n0 , (6)
where κ is a matching propensity parameter and n0 is the number of points in the template
configuration µ0.
The joint log posterior for the model is
− 1
2σ2
|I|∑
i=1
ni∑
j=1
n0∑
j′=1
Mijj′||Aixij + τi − µ0j′||2 − 3|I| log(
√
2σ)
−|I| log(κ)− β/σ − (α− 1) logσ + log(cos θ13).
(7)
For given |I| there can be multiple configuration sets maximising the joint log posterior. It
should be noted that the model is identifiable only up to the equivalence class of the form
of µ0 i.e. Aµ0 + τ , where A is a rotation matrix and τ a translation vector. Given µ0 and
I, the conditional distribution of all the parameters (Ai, τi, σ and M) can be obtained in a
hierarchical pairwise method, using MCMC as follows:
We have explicit full conditionals for τ and σ and these parameters are updated using Gibbs
sampling; Mijj′ is updated using Metropolis-Hastings (Green and Mardia, 2006). With Euler
angles θ12, θ13 and θ23 parameterising the rotation A, θ12 and θ23 are updated using Gibbs
sampling from their full conditional von Mises distributions. Metropolis-Hastings is used to
update θ13.
2.3 Estimating µ0
We note from equation (7) that log p(µ0|rest) is (except for a constant)
− 1
2σ2
|I|∑
i=1
ni∑
j=1
n0∑
j′=1
Mijj′||Aixij + τi − µ0j′||2. (8)
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Thus a point estimate µˆ0 of µ0, where µ0 = (µ01, . . . , µ0n0)
T , is given by
µˆ0j′ =

 |I|∑
i=1
ni∑
j=1
Mijj′||Aixij + τi||



 |I|∑
i=1
ni∑
j=1
Mijj′


−1
(9)
j′ = 1, . . . , n0, up to equivalence class of form.
Hence we can estimate µˆ0 given point estimates of all other parameters. We now assume that
we can compute goodness of fit statistics, S, for selecting “optimal” estimates of µˆ0 using
only these pairwise estimates of the other parameters from any pairwise alignment method
giving matching matrices M and the corresponding posterior probability matrix of matches,
P , as well as estimates of the transformation parameters A and τ , such as GM and EM
(Kent, Mardia and Taylor, 2004) algorithms. Our goodness of fit statistics S then depend
on M and P in building µ0.
We first consider a simple example with 3 configurations to construct stage by stage estimates
of µ0. Suppose now that for pairs of configurations (1, 2), (1, 3) and (2, 3) we obtain matching
matrices M and posterior probability matrices P (1, 2), P (1, 3), P (2, 3), where the (i, j)th
element of P (1, 2) is the estimated posterior probability of matching the ith point of x1 to
the jth point of x2 and so on. Now say S selects the subset of x1 and x2 to be the “best”. Then
we can obtain the estimate µˆ
(1)
0 from equation (9), as all the parameters are now known.
We now apply pairwise comparison of µˆ
(1)
0 and x3 and calculate the statistic S. If S rejects
this new subset, we keep µˆ
(1)
0 as our estimate, otherwise we calculate µˆ
(2)
0 from equation (10)
as the new estimate of µ0 using the matching subset of µˆ
(1)
0 and x3. In this case these are
the only options but even for 4 configurations, there can be many options, including the
following multiple estimates for µ0.
(1) µˆ0 may be obtained using all 4 configurations.
(2) µˆ0 may include only 3 configurations such as (1, 2, 3) and (1, 3, 4).
(3) µˆ0 may include only 2 configurations such as (1, 2) or (3, 4).
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We give full details of a hypothetical example using six configurations in the supplementary
material.
3. Implementation of the HT Model
We consider a point estimate for µ0 within the equivalence class of form [µ0], i.e. Aµˆ0 + τ
is equivalent to µˆ0. We propose removing this non-identifiability for µ0 by taking µ0 to be
in the configuration space of one of the observed configurations and use a MAP estimator.
Since our priors for A and τ in (3) are symmetric, it does not matter which configuration
is used as reference. We estimate model parameters for hierarchical templates conditional
on µ0, which requires pairwise alignment involving µ0. That is we need to embed a pairwise
alignment algorithm such as the EM algorithm (Hancock and Cross, 1998; Luo and Hancock,
2001; Kent et al., 2004) or Bayesian alignment (Green and Mardia, 2006; Dryden et al., 2007;
Schmidler, 2007) within a hierarchical structure. Here we use the GM algorithm which is a
fully Bayesian pairwise alignment methodology giving all the ingredients for comprehensive
Bayesian inference including the log-posterior, matching probabilities and point estimates
that can be used to summarise pairwise alignments.
3.1 Mechanism of the HT algorithm
The HT algorithm starts by considering each single configuration as a template and, taking
a bottom-up approach, successively merges pairs of templates to form new templates. At
each iteration, all pairwise alignments of items in the list of templates are evaluated and
the best pair, according to some criteria, are merged to form a new template. The new
template is added to the list, the two merged items are removed and the process is repeated.
The algorithm continues until no pairwise alignment satisfies the merging criteria. For
computational efficiency, details of pairwise alignments involving items which are not merged
are kept, so they do not have to be re-evaluated at the next iteration.
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Here we have used a template merging criterion based on the geometric mean of matching
probabilities for declared matches, G =
∏
p
(1/n0)
jk , where n0 is the number of matches given
by the estimate Mˆ of the matching matrixM , which on the log scale is equal to n−10
∑
log pjk.
The merging criteria we have used is to select the pair of configurations (a, b) such that
(a, b) = argmax
a,b
Ga,b, (10)
where Ga,b is the geometric mean of the pairwise alignment between templates a and b.
Additionally, we impose the threshold values gmin and nmin, so that the conditions G > gmin
and n0 > nmin must be satisfied for a merge to be accepted. Hence, if no pair satisifes
this criteria then the algorithm will terminate. An outline of an example iteration of the
algorithm is given below. In the supplementary material, we give full details of a possible
algorithm flow for a hypothetical example involving six configurations.
3.2 Outline Iteration
We now outline an example iteration for C = 11 configurations, x1 . . . x11. We denote
our list of templates by X . Our initial list of templates is just the 11 configurations, so
X = {x1 . . . x11}. The choice of C = 11 is motivated by the real examples we consider in
section 4.
Let r denote the iteration number for the algorithm. At the rth iteration we denote a
vector of matching probabilities for the optimal pairwise alignment between the ith and
i′th configurations or templates by P r(i,i′) = (p
r
1, . . . , p
r
n0
), where n0 = n
r
0(i,i′) is the number of
matched points from the optimal pairwise alignment at iteration r. Let Gr(i,i′) =
n0∏
l=1
(prl )
1/n0 ,
the geometric mean of matching probabilities. Example iterations would proceed as follows:
(1) Consider all pairs of configurations. There are 11C2 = 55 pairwise matches. For each
pairwise match, between configurations xi and xi′ say, obtain the number of matching
atoms n10(i,i′), the corresponding matching probabilities P
1
(i,i′) and geometric mean G1(i,i′).
(2) Merge matching configurations with the highest G1(i,i′) meeting the merge criteria. Say
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this pair is (1, 2) with j = 1, . . . , n0 corresponding points. Form a template denoted by
Tii′ with the coordinates for point j given by mean coordinates of the j
th corresponding
points in the registered configurations. Note that the new template consists of n0 points,
formed using only the n0 matched points from the pairwise alignment.
(3) Configurations 1 and 2 are removed from the set of configurations as they are a subset
of a newly formed template; the new template Tii′ is added to the list of configurations
as x12, so X = {x3, x4, . . . , x12}.
(4) Match the newly formed template, T12, against configurations x3, . . . , x11. Obtain number
of matching atoms n20(12,i′), matching probabilities P
2
(12,i′) and G2(12,i′), i′ = 3, . . . , 11.
(5) The second iteration considers a set of pairwise alignments among configurations x3, . . . , x11
as well as new pairwise alignments involving T12 and configurations x3, . . . , x11 evaluated
in step (4), i.e we begin the cycle again in step (2). Note that for previously considered
pairs (i, i′) that have not been merged, P r(i,i′) = P
r−1
(i,i′) and Gr(i,i′) = Gr−1(i,i′). These are being
tracked together with the number of matches, nr0(i,i′), so we do not need to recompute
them.
For following iterations only pairs of configurations or templates that are not merged
in previous iterations are considered to be merged to form a new template. Successive
templates are formed hierarchically whereby the coordinates for the template involving
a set of configurations, I ⊆ {x1, x2, . . . , x11} are µˆI = 1|I|
∑
i′∈I
xi′ .
Plausible pharmacophores are templates consisting of say q > 2 configurations and
n0 > 3 atoms.
The algorithm may output one template, containing matched points across some or all
configurations, or multiple templates derived from matched points from different subsets
of configurations. We do not allow overlap between subsets, so each configuration can only
contribute to at most one template. Part of our strategy is analogous to that of an agglom-
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erative clustering algorithm, (see, for example, Mardia, Kent and Bibby, 1979, pp. 371-373),
but with some important differences. Our objects are point configurations rather than single
points, and we require a similarity measure between pairs of configurations, or templates.
Additionally, our similarity measure is dynamic, in the sense that new similarity measures
must be calculated from pairwise alignments between a newly formed template and all
existing templates. Therefore, at each stage we have an updated list of similarity measures,
consisting of all measures previously calculated as well as the new measures obtained from
pairwise alignments involving the most recently formed template.
The algorithm has computational complexity O(C2) for the number of pairwise alignments
performed. Recall that we denote the iteration number of the algorithm by r, where r > 1.
We begin with a finite number C of configurations. Note that for the first step, r = 1, we need
to perform C(C−1)
2
pairwise alignments. For each subsequent step r > 2, we have C − r + 1
configurations, or templates, and we need only perform C − r pairwise alignments between
the template formed at step r − 1 and the other templates in our list. The total number of
iterations is at most C, since after C iterations we would have only one template remaining.
Thus the algorithm has the polynomial cost complexity of O(C2). Additionally, an extra
layer of cost complexity is added for each pairwise alignment performed, which depends on
the sizes of the configurations.
3.3 Restricted Transformations
There are situations where we may wish impose restrictions on transformation parameters
(rotation matrices A and translation vectors τ) when identifying the template from pre-
aligned ligands. For example we might
(1) allow only small deviations of Ai from identity matrix I3 and small deviations for τi from
the zero vector;
(2) set Ai = I3 and τi = 0 to prohibit any degree of transformation.
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These restrictions would be important in situations where alternative geometrical alignments
are to be avoided, such as in the presence of ring-like structures or when the ligands
have already been aligned. In our application described in Section 4 we do not consider
transformation in aligning the ligands when identifying plausible pharmacophores as they
are pre-aligned in some meaningful sense. However, there may be occasions when one would
not wish to restrict transformations, such as when searching a database of compounds for
matches to a pharmacophore template. In this case, the compounds would not necessarily
have any meaningful pre-alignment.
3.4 Atom type information
We can consider that points are “coloured” with the interpretation that like-coloured points
are more likely to be matched than unlike-coloured ones. In the context of searching for
commonality between ligands, one might take the atom elements (carbon, nitrogen, etc) as
the colour information. We can specify the matching propensity parameter κ as a function
of concomitant information like atom types to parameterise the tendency a priori for points
to be matched. In pairwise alignment, we have either a colour match or mismatch. With
multiple alignment there can be many sophisticated ways of scoring colour-mismatching, as
the number of different colours in a match can range from one to say S > 2, the total number
of colours. Here we consider a simple way whereby we have binary categorization as follows:
• matches with all atoms having the same type,
• matches with at least one atom type different.
A priori, matching probabilities are proportional to exp (γ) for same colour matches and
exp (δ) for different colour matches, where γ and δ are specified “award/penalty” parameters
for matching or mismatching colours, where γ > δ. For example, setting γ = 1.0 and δ =
−0.5 awards colour matching twice as much as penalizing colour mismatching. Note that
δ −→ −∞ prohibits matching different colours, for instance element types.
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4. Application
We have two sets of eleven ligand configurations from multiple structural alignments of
ligand binding sites in SitesBase (Gold and Jackson, 2006), one for a protein kinase and
one for trypsin. SitesBase entries were automatically formed from the protein data bank, or
PDB (Berman et al., 2000), by locating the local protein environment (amino acids within
5A˚) around bound ligands (identified by PDB HETATM records, as described by Gold and
Jackson (2006)). For simplicity we will refer to the set of ligands from a series of protein
kinases as 1ATP and label these 1 − 11. Similarly, we will refer to the set of ligands from
a series of trypsin-ligand bound structures as 3PTB and label these 12− 22. These refer to
two sets of ligand binding sites which in each case are superimposed on a single site. In the
case of 1ATP, ten more distantly related protein kinase binding sites were superimposed on
a subunit of protein kinase 1ATP. They contain a diverse set of kinase inhibitors. In the case
of 3PTB, ten more trypsin-ligand bound complexes were superimposed on the site of trypsin
bound to benzamidine, 3PTB. The ligands are shown in Figure 1 and the sizes (number of
atoms) of each ligand are given below in Tables 1 and 2.
[Table 1 about here.]
[Table 2 about here.]
Finding a pharmacophore model for the 1ATP ligands by manual inspection is considered
difficult even for an experienced biologist, while finding a pharmacophore model for the 3PTB
ligands is an easier task. Using our HT algorithm we find three subsets of conformations for
the 1ATP data and two subsets of configurations for the 3PTB data. From these we can
obtain templates capturing the geometry of the matched points in each subset. Since the
ligands are pre-aligned by their binding to other proteins, we set A = I3 and τ = 0 to
prohibit spatial transformation. Allowing unrestricted transformation gave either the same
(1ATP) or very similar (3PTB) results. With slight tuning of the hyperparameters for σ−2
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we obtain the same results for the 3PTB case as well. In the following two applications, we
keep the hyperparameters for σ−2 fixed throughout, with α = 1 and β = 5.
[Figure 1 about here.]
4.1 1ATP ligands
We denote 1ATP ligands by numbers 1, 2, . . . , 11. Using the HT algorithm we identify
common atoms in three different subsets, each consisting of three configurations. Here
we have used the geometric mean threshold gmin = 0.5 and the cost ratio K = 0.1, as
experience showed these values provide a good balance between allowing templates to merge
but preventing the final templates becoming too general, in agreement with expert opinion.
We also impose the restriction nmin > 3, meaning acceptable templates must consist of at
least 3 atoms.
Table 3 shows the configurations contributing to each of the templates found and the number
of atoms they have in common. Figure 2 shows the geometry of the configurations. We
use colouring information in order to distinguish between atoms of different elements, as
described in section 3.4. It is more sensible from a chemical viewpoint to match points of
the same element, hence we discourage matches between different element types. It is still
possible to match elements of different types if their interpoint distances are relatively small.
Here we use the values γ = 0 and δ = −20 to discourage matches between elements of
different types; no matches between different elements were found in this case. If we do not
use colouring information, the three subsets of configurations found are the same as those
given in Table 3, but there are differences in a small number of the individual matches
between points. We find one match between different elements in template A and three
matches between different elements if templates B and C. There are two fewer points in
template C when colouring information is used, and the same number of points in templates
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A and B. We give details of the results obtained without using colouring information in the
supplementary material.
[Table 3 about here.]
[Figure 2 about here.]
4.2 3PTB ligands
We denote the eleven 3PTB ligands by numbers 12, 13, . . . , 22. The HT algorithm identifies
2 subsets of configurations. We have used the values gmin = 0.5, K = 0.1 and nmin = 3 as
before. Once again, we use colouring information to distinguish between different element
types, with δ = −20. The configurations contributing to each template are shown in Table 4
and their geometry in Figure 3. The details of the results obtained when colouring information
is not used are given in the supplementary material. We find no matches between atoms of
different elements, regardless of whether we use colouring information or not.
[Table 4 about here.]
[Figure 3 about here.]
5. Discussion
In this paper we have proposed a fast method for aligning multiple configurations of unla-
belled point sets and identifying common matched points across all configurations, or subsets
of them, in order to derive templates capturing the geometry of the matched points. Our
method is able to identify multiple subsets of configurations. In this sense, part of the im-
plementation strategy is analogous to an agglomerative clustering algorithm, but with some
important differences. The algorithm is implemented via a multi-stage pairwise alignment
approach, so at each stage we have an updated “similarity measure” based on a criteria
calculated from the pairwise matching probabilities given by the probability matrices P , the
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set of which is updated at each stage to include alignments involving newly-formed templates.
The algorithm continues to merge templates until no further acceptable merges meeting the
criteria can be formed. An important advantage of our method is the ability to identify
multiple subsets of configurations to derive templates representing the common points in
each. From the perspective of our current application, this is important in pharmacophore
modelling, where experts would expect more than one plausible pharmacophore as ligands
may bind active sites in more than one way. Note that we have concentrated here on rigid
body transformations (form analysis). This choice is motivated by our application described
in this paper, but the methodology is applicable to other transformations (see, for example,
Dryden and Mardia, 1998) used in shape analysis.
In the implementation we have described in this paper, we remove items merged to form
new templates at each stage, so any given ligand can contribute to at most one template.
An alternative approach allowing for “overlapping” templates, would be to not remove items
from the list of available objects in step (3) of the HT algorithm. The resulting templates
would overlap in the sense that an individual ligand could feature in more than one template.
We could also consider the number of ligands contributing to a template when discriminating
between pairwise alignments to decide on a merge at each stage. For example, a scoring
function of the form
(Nwn0)
−1
∑
log pjk,
where N is the number of configurations contributing to a template, would weight templates
with larger values of N more favourably for w > 1. This parameter could be adjusted
depending on how much weight one wishes to place on more inclusive templates. The case
where w = 0 reduces to the situation we have in the examples in this paper, where the
number of configurations contributing to a template has not been considered as part of the
process of evaluating them.
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The algorithm is computationally simple, with complexity O(C2), and fast to implement. The
tracking of all acceptable templates, beyond those chosen as optimal at each stage, prevents
the need to reevaluate pairwise alignments, saving considerable computation. It should be
noted that the complexity also depends on the choice of pairwise alignment method, in this
case that given by Green and Mardia (2006).
The method we have developed here aims to construct templates representing common
points in multiple configurations. Each template is essentially an object which captures
the average geometrical information of common points in an optimal way. In the context
of the applications described here, it should be noted that a template does not represent a
chemical entity in itself. The geometrical information contained in a template could however
be used to identify the key features common to each configuration and their relative spatial
orientation, so that a plausible pharmacophore model could be constructed. Further work
could require templates to satisfy chemical constraints, in order to determine a representative
molecule directly.
Supplementary Materials
Web Appendices, Tables, and Figures referred to in Sections 3 and 4 are available under the
Paper Information link at the Biometrics website http://www.biometrics.tibs.org.
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a) 1ATP and b) 3PTB ligands
Figure 1. Sets of 1ATP and 3PTB ligands.
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Template A and Template B
Template C
Figure 2. 1ATP ligands contributing to the templates found by the HT algorithm. The
template geometry is defined by the mean position of common matching atoms.
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Template A and Template B
Figure 3. 3PTB ligands contributing to the templates found by the HT algorithm. The
template geometry is defined by the mean position of common matching atoms.
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Table 1
Sizes of 1ATP Ligands
Ligand No. 1 2 3 4 5 6 7 8 9 10 11
No. of Atoms 31 35 35 18 27 36 20 18 27 35 37
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Table 2
Sizes of 3PTB Ligands
Ligand No. 1 2 3 4 5 6 7 8 9 10 11
No. of Atoms 9 20 22 40 41 25 24 72 9 11 14
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Table 3
Probable templates for 1ATP
Template # Configurations # of common atoms
A 2 3 6 35
B 4 5 7 18
C 9 10 11 24
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Table 4
Probable templates for 3PTB
Template # Configurations # of common atoms
A 19 21 11
B 12 14 15 16 17 18 20 22 9
